Sagility Ltd
Incorporated in July 2021, Sagility India Limited (formerly Berkmeer India Pvt. Ltd) provides healthcare-focused technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.[1]
- Market Cap ₹ 21,314 Cr.
- Current Price ₹ 45.5
- High / Low ₹ 56.4 / 27.0
- Stock P/E 32.0
- Book Value ₹ 17.8
- Dividend Yield 0.00 %
- ROCE 9.58 %
- ROE 7.38 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Stock is trading at 2.56 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -15.0%
- Company has a low return on equity of 4.89% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 8m | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 923 | 4,218 | 4,754 | 5,570 | 5,886 | |
| 730 | 3,179 | 3,665 | 4,263 | 4,473 | |
| Operating Profit | 193 | 1,039 | 1,088 | 1,307 | 1,413 |
| OPM % | 21% | 25% | 23% | 23% | 24% |
| 18 | 5 | 28 | 47 | 79 | |
| Interest | 65 | 215 | 185 | 127 | 117 |
| Depreciation | 147 | 644 | 689 | 467 | 475 |
| Profit before tax | -2 | 186 | 242 | 760 | 900 |
| Tax % | 152% | 23% | 6% | 29% | |
| -5 | 144 | 228 | 539 | 665 | |
| EPS in Rs | -0.02 | 0.75 | 0.53 | 1.15 | 1.42 |
| Dividend Payout % | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 82% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 291% |
| TTM: | 220% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 5% |
| Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 1,919 | 1,919 | 4,285 | 4,679 |
| Reserves | 2,108 | 4,288 | 2,158 | 3,657 |
| 4,788 | 2,896 | 2,532 | 1,402 | |
| 1,271 | 1,427 | 1,554 | 1,179 | |
| Total Liabilities | 10,085 | 10,529 | 10,529 | 10,917 |
| 8,621 | 8,607 | 8,667 | 8,997 | |
| CWIP | 5 | 0 | 6 | 0 |
| Investments | -0 | -0 | -0 | -0 |
| 1,459 | 1,922 | 1,856 | 1,920 | |
| Total Assets | 10,085 | 10,529 | 10,529 | 10,917 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -32 | 857 | 973 | 1,214 | |
| -7,711 | -101 | -463 | -958 | |
| 8,116 | -545 | -751 | -256 | |
| Net Cash Flow | 374 | 211 | -241 | -0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 366 | 92 | 91 | 83 |
| Inventory Days | ||||
| Days Payable | ||||
| Cash Conversion Cycle | 366 | 92 | 91 | 83 |
| Working Capital Days | 58 | 13 | -6 | 25 |
| ROCE % | 5% | 5% | 10% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17 Oct - Details of investors call to be held on October 29, 2025, pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI …
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Oct - RTA confirms no dematerialisation/rematerialisation requests for quarter ended September 30, 2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
7 Oct - Investor/analyst webinar on unaudited Q2 and H1 results on 29 Oct 2025, 7:30 PM IST.
-
Board Meeting Intimation for Considering, Approving And Taking On Record The Unaudited Financial Results For The Quarter And Half Year Ended On September 30, 2025, Along With Limited Review Report Thereon
7 Oct - Board meeting Oct 29, 2025 to approve Q2/half-year unaudited results; trading window closed Oct 1–31, 2025.
- Closure of Trading Window 25 Sep
Concalls
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
Market Share [1] Headquartered in Bangalore, the company serves only US customers. It holds 1.23% of the U.S. healthcare outsourcing market as of 2023.
Client Segmentation[2]
- Payers: Health insurance companies that finance and reimburse healthcare services. Sagility provides them with services like claims processing, payment integrity, and clinical management.
- Providers: Hospitals, physicians, and diagnostic centers, with services focused on revenue cycle management (RCM) that includes insurance verification, billing, and accounts receivable follow-up.